Das28 Score Calculator

The DAS28 combines four inputs into one number: a tender joint count and a swollen joint count over the same 28 joints, an acute phase reactant, and the patient global health assessment on a 0 to 100 mm visual analog scale. The transformations in the formula are not cosmetic. Joint counts enter as square roots because the difference between 0 and 4 affected joints matters far more clinically than the difference between 20 and 24, and the square root compresses the upper range accordingly. ESR enters as a natural logarithm because its relationship to inflammation is multiplicative rather than additive. The coefficients 0.56, 0.28, 0.70, and 0.014 were fitted by regression, and the larger weight on tender joints than swollen joints falls directly out of that fit. Swelling is the more specific sign of synovitis, but tenderness carried more of the variance in the decisions used as the criterion. Thresholds are remission below 2.6, low activity below 3.2, moderate from 3.2 to 5.1, and high above 5.1, with EULAR response defined jointly by the achieved score and the change from baseline. The CRP variant uses different coefficients and a 0.96 constant and yields systematically lower values, so the two must never be mixed within one patient timeline. The 28-joint set omits the feet and ankles, frequently involved in rheumatoid arthritis. ESR rises with age, anaemia, female sex, and obesity independent of disease, and the patient global item absorbs pain from fibromyalgia or osteoarthritis, which together explain why ultrasound often finds residual synovitis in patients formally in DAS28 remission.

The Disease Activity Score originated in Nijmegen in the Netherlands, where Desiree van der Heijde, Piet van Riel and colleagues took an unusual approach to validation. Rather than defining disease activity theoretically, they observed which patients rheumatologists in routine clinics actually decided to start or intensify treatment for, and treated those decisions as the external criterion against which candidate variables were weighted. The resulting score, published in 1990, used the Ritchie articular index and a 44-joint swollen count. Because counting 44 joints was impractical in busy clinics, Monique Prevoo and colleagues from the same group produced the reduced 28-joint version in Arthritis and Rheumatism in 1995, showing that the shorter count lost little information while roughly halving examination time. EULAR response criteria built on the score followed in 1996, and DAS28 became the standard primary endpoint in rheumatoid arthritis trials through the biologic era, which in turn made its thresholds the basis for drug reimbursement rules in several countries. A CRP-based variant was introduced to accommodate laboratories moving away from ESR and settings where ESR is unreliable. Criticism that DAS28 classifies as being in remission patients who still have active joints prompted the simpler CDAI and SDAI indices from Smolen and Aletaha, and the stricter ACR and EULAR Boolean remission definition published in 2011.